MSANTD3-TMEFF1

Chr 9

MSANTD3-TMEFF1 readthrough

Also known as: C9orf3-TMEFF1, C9orf30-TMEFF1

The MSANTD3-TMEFF1 fusion protein combines DNA-binding domains from MSANTD3 with transmembrane and growth factor-like domains from TMEFF1 through naturally occurring read-through transcription. No pediatric neurological diseases have been definitively associated with mutations in this fusion transcript. The moderate loss-of-function intolerance scores (pLI 0.24, LOEUF 0.51) suggest some evolutionary constraint but do not indicate strong haploinsufficiency.

ResearchSummary from RefSeq
LOEUF 0.51
Clinical SummaryMSANTD3-TMEFF1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.51LOEUF
pLI 0.237
Z-score 3.17
OE 0.24 (0.130.51)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.07Z-score
OE missense 0.78 (0.680.89)
142 obs / 182.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.24 (0.130.51)
00.351.4
Missense OE0.78 (0.680.89)
00.61.4
Synonymous OE0.98
01.21.6
LoF obs/exp: 5 / 20.5Missense obs/exp: 142 / 182.7Syn Z: 0.12

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MSANTD3-TMEFF1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →